Cellebrite DI Ltd. (NASDAQ:CLBT) Short Interest Down 17.1% in November

Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) saw a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 1,450,000 shares, a decline of 17.1% from the November 15th total of 1,750,000 shares. Based on an average trading volume of 1,300,000 shares, the days-to-cover ratio is currently 1.1 days. Approximately 1.7% of the shares of the company are short sold.

Institutional Trading of Cellebrite DI

A number of hedge funds have recently bought and sold shares of CLBT. California State Teachers Retirement System grew its holdings in Cellebrite DI by 9.1% in the 1st quarter. California State Teachers Retirement System now owns 56,953 shares of the company's stock valued at $631,000 after buying an additional 4,734 shares in the last quarter. Tower View Wealth Management LLC increased its position in Cellebrite DI by 6.2% during the second quarter. Tower View Wealth Management LLC now owns 129,147 shares of the company's stock worth $1,543,000 after purchasing an additional 7,542 shares during the last quarter. Concurrent Investment Advisors LLC purchased a new position in Cellebrite DI during the second quarter worth about $835,000. nVerses Capital LLC acquired a new position in Cellebrite DI in the 2nd quarter valued at about $103,000. Finally, Pembroke Management LTD grew its stake in shares of Cellebrite DI by 104.9% in the 2nd quarter. Pembroke Management LTD now owns 1,535,726 shares of the company's stock valued at $18,352,000 after buying an additional 786,310 shares during the period. Institutional investors and hedge funds own 45.88% of the company's stock.

Cellebrite DI Stock Performance

Shares of NASDAQ:CLBT traded up $0.41 during trading on Monday, reaching $20.29. The stock had a trading volume of 571,074 shares, compared to its average volume of 1,178,313. Cellebrite DI has a 1-year low of $7.91 and a 1-year high of $21.72. The stock has a market cap of $4.18 billion, a PE ratio of -12.83, a PEG ratio of 2.71 and a beta of 1.51. The business has a fifty day moving average price of $18.93 and a 200-day moving average price of $15.82.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.05. The company had revenue of $106.90 million for the quarter, compared to analysts' expectations of $102.06 million. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The firm's quarterly revenue was up 27.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.09 EPS. Sell-side analysts expect that Cellebrite DI will post 0.32 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on CLBT. Needham & Company LLC raised their target price on Cellebrite DI from $17.00 to $21.00 and gave the company a "buy" rating in a research report on Thursday, November 7th. Craig Hallum raised their price objective on Cellebrite DI from $23.00 to $24.00 and gave the company a "buy" rating in a report on Thursday, November 7th. JPMorgan Chase & Co. upped their target price on Cellebrite DI from $22.00 to $24.00 and gave the stock an "overweight" rating in a research note on Monday. Finally, TD Cowen increased their target price on Cellebrite DI from $20.00 to $23.00 and gave the company a "buy" rating in a research report on Monday, September 23rd. Eight research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Cellebrite DI currently has a consensus rating of "Buy" and an average price target of $20.57.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.